Conference on Cannabinoid-Based Medicines
Date and time
Location
Online event
Refund policy
Contact the organiser to request a refund.
Eventbrite's fee is nonrefundable.
Conference on Cannabinoid-Based Medicines: International Research Innovations to Transform Patient Care
About this event
BRINGING TOGETHER DIVERSE STAKEHOLDERS TO SHARE AND LEARN AT THE INTERSECTION OF SOCIETY AND SCIENCE, POLICY AND PRACTICE.
Highlights include:
- Pre-clinical to clinical trials with cannabinoid-based medications: Opportunities and challenges
- Opioids in patients with chronic pain
- Cannabinoids-based products and research gaps to fill
- Real-world data
- Extract versus synthetic in researching cannabinoids
- Regulatory challenges in cannabinoids research
Read more and download the agenda here
Suited for healthcare professionals, clinical researchers, patients and patient advocates, government policy makers, licensed medical cannabis producers and sellers and other stakeholders to discuss the latest developments in the medical cannabis industry.
The audience will tune into live-streamed panels, keynotes, and other engaging features such as interactive polling and pre- and post-event surveys.
Keynote speakers and panellists are selected to present diverse perspectives and expertise in different fields of medical research.
Recieve a ticket for free
by filling out and submitting a digital 15-minute survey before the event. Survey data will be anonymized and shared to prompt meaningful discussion during the event. Discount code is shared at the end of the survey.
This event is in English only, if you would like information in French, please email us at forum@santecannabis.ca.
Cet événement est en anglais, si vous souhaitez obtenir des informations en français, veuillez nous envoyer un courriel à forum@santecannabis.ca
Join us in March as well:
CCM : LEUR INTÉGRATION À LA PRATIQUE CLINIQUE AU QUÉBEC
1:00 -4:30 pm EDT March 24th, 2021
(EVENT IN FRENCH) Focused on medical cannabis in Quebec, all programming and presentations are offered in French only.
As topics cover therapeutic uses of medical cannabis, the information is intended for adults 18 years or older.